Inventor · disambiguated record
Kanako Tatsumi
Also filed as: TATSUMI KANAKO
6 granted patents·8 pending applications·19 citations·filing 2013–2025
78Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD14
Top patents by PatentIndex Score
14 records- 0194US11912989B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 27, 2024·3 cites·14 claims
- 0293US11673947B2Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 13, 2023·7 cites·51 claims
- 0389US10961530B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Mar 30, 2021·6 cites·21 claims
- 0483US12304960B2Anti-CD137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 20, 2025·3 cites·27 claims
- 0578US2023279099A1Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0678US2024158785A1Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0777US12415857B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·21 claims
- 0871US12448451B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 0963US2024043515A1Heterodimer fc polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1062US2023058982A1Anti-ctla-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1162US2025388689A1Anti-cd137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1259US2023416371A1Heterodimer fc polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1355US2023322898A1Pharmaceutical composition comprising cell expressing chimeric receptorCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1453US2015166654A1Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kanako Tatsumi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →